HyperSolar, Inc. (PINK:HYSR) reached up 35.94% in morning trading to $.0435 with 2M shares traded. HyperSolar is developing a breakthrough, low cost technology to make renewable hydrogen using sunlight and any source of water, including seawater and wastewater. Unlike hydrocarbon fuels, such as oil, coal and natural gas, where carbon dioxide and other contaminants are released into the atmosphere when used, hydrogen fuel usage produces pure water as the only byproduct. HyperSolar, Inc. (PINK:HYSR) today announced that it has completed an end-to-end laboratory scale demonstration using renewable hydrogen produced from sunlight and water to generate electricity in a fuel cell.
Mitek Systems, Inc. (NASDAQ:MITK) reached up 17.64% in morning trading to $3.435 with 400K shares traded. Mitek Systems is a mobile imaging software solutions provider that allows users to remotely deposit checks, pay their bills, get insurance quotes, and transfer credit card balances by snapping a picture with their camera-equipped smartphones and tablets instead of using the device keyboard. Mitek's technology increases convenience for the consumer by eliminating the need to go to the bank branch or automated teller machine, and dramatically reduces processing and customer acquisition costs while increasing customer retention. Mitek Systems, Inc. (NASDAQ:MITK) yesterday announced financial results for the third quarter of fiscal 2012, which ended June 30, 2012. Total revenue for the third quarter of fiscal 2012 was $3.2 million compared to total revenue of $3.0 million for the third quarter of fiscal 2011. Software revenue was $2.5M in the third quarter of fiscal 2012, compared to $2.4M in the third quarter of fiscal 2011. Maintenance and professional services revenue was $698,000 in the third quarter of fiscal 2012, compared to $579,000 in the third quarter of fiscal 2011. Total operating expenses for the third quarter of fiscal 2012 were $4.8 million compared to $2.2 million for the third quarter of 2011.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) reached up 12.15% in morning trading to $1.20 with 2M shares traded. Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) yesterday announced that it has completed the previously announced underwritten public offering of 33,000,000 shares of its common stock, offered at a price to the public of $1.00 per share. In addition, the Company has sold 4,950,000 shares of its common stock at a price to the public of $1.00 per share pursuant to the underwriters' option to purchase additional shares, resulting in a total public offering of 37,950,000 shares. The gross proceeds to the Company from the sale of shares in this offering, before deducting customary underwriting discounts and commissions, were $37,950,000. Anthera intends to use the net proceeds from this offering for general corporate purposes.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at firstname.lastname@example.org.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE